NRT Smoking Cessation Aids in Morocco
Euromonitor International's NRT Smoking Cessation Aids in Morocco market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 45 | Publication date: Aug 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN MOROCCO : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Number of Smokers by Gender 2003-2008
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 5 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 6 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 8 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - MOROCCO
AFRIC-PHAR - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Afric-Phar: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Afric-Phar: Competitive Position 2008
COOPER MAROC - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Cooper Maroc: Key Facts
Summary 4 Cooper Maroc: Operational Indicators
Company Background
Production
Summary 5 Cooper Maroc: Production Statistics 2007
Competitive Positioning
Summary 6 Cooper Maroc: Competitive Position 2008
LABORATOIRES LAPROPHAN - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Laboratoires Laprophan: Key Facts
Summary 8 Laboratoires Laprophan: Operational Indicators
Company Background
Production
Summary 9 Laboratoires Laprophan: Production Statistics 2007
Competitive Positioning
Summary 10 Laboratoires Laprophan: Competitive Position 2008
LABORATOIRES PHARMA 5 - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Laboratoires Pharma 5: Key Facts
Summary 12 Laboratoires Pharma 5: Operational Indicators
Company Background
Competitive Positioning
Summary 13 Laboratoires Pharma 5: Competitive Position 2008
LABORATOIRES SOTHEMA - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Laboratoires Sothema: Key Facts
Summary 15 Laboratoires Sothema: Operational Indicators
Company Background
Production
Summary 16 Laboratoires Sothema: Production Statistics 2007
Competitive Positioning
Summary 17 Laboratoires Sothema: Competitive Position 2008
MAPHAR, LABORATOIRES - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Maphar, Laboratoires: Key Facts
Summary 19 Maphar, Laboratoires: Operational Indicators
Company Background
Competitive Positioning
Summary 20 Maphar, Laboratoires: Competitive Position 2008
PROMOPHARM - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Promopharm: Key Facts
Summary 22 Promopharm: Operational Indicators
Company Background
Competitive Positioning
Summary 23 Promopharm: Competitive Position 2008
SMP BOTTU - OTC HEALTHCARE - MOROCCO
STRATEGIC DIRECTION
KEY FACTS
Summary 24 SMP Bottu: Key Facts
Summary 25 SMP Bottu: Operational Indicators
Company Background
Competitive Positioning
Summary 26 SMP Bottu: Competitive Position 2008
OTC HEALTHCARE IN MOROCCO
EXECUTIVE SUMMARY
Health and wellness drive growth of OTC Healthcare in 2008
Cough, cold and allergy (hay fever) remedies remains leading category
Key players remain active in their areas of operation
Chemists/pharmacies remains the leading channel of distribution
OTC Healthcare expected to benefit from improvements in health education
KEY TRENDS AND DEVELOPMENTS
Positive impact of governmental health policies on OTC Healthcare
Improvements in economy encourage growth of OTC Healthcare
Hectic lifestyles boost awareness of health
Health and wellness has increasing influence on OTC Healthcare
Chemists/pharmacies, dominant distribution channel in OTC Healthcare
MARKET INDICATORS
Table 9 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 10 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 11 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 16 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 17 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 18 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
DEFINITIONS
Summary 27 Research Sources